惊声尖笑

Beijing's first cross-provincial subway line begins trial run_我的网站

女人我最大

A | “三五年内，沪市生物医药行业的估值还有提升空间。 (ECNS) -- Beijing Subway Line 22, the capital's first urban rail route linking neighboring Hebei Province, began emptyload trial operations Tuesday, according to the Beijing Major Projects Construction Headquarters Office and BII Railway Transportation Technology Holdings Company Limited. Stretching about 79.1 kilometers with a speed up to 160 km/h on elevated sections and 120 km/h underground, Subway Line 22 runs from Hongmiao in Chaoyang district to Pinggu New Town, with 20 stations in total, including 15 in Beijing and five in Hebei. Once operational, travel from Yanjiao Town in Hebei to Beijing's Sub-Center Station will take just nine minutes, while journeys to Hongmiao Station in the capital's central business district will be about 28 minutes. Officials described Line 22 as a "major transport artery" for regional integration. The route will connect with multiple existing lines, including transfers at Hongmiao to Line 14, Guanzhuang to Line 1, Beiguan to Line 6, and Beijing Sub-Center Station to Line 6 and the Beijing-Tangshan intercity railway. The line is expected to be ready for opening by year's end. (By Gong Weiwei) 。”在近日举行的一场沪市生物医药行业沙龙中，富国基金权益研究部行业研究员杨波说。近两个月来，医药股迎来一波行情。以全指医药为例，该指数自6月22日以来累计涨幅达15.64%。